Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6912-6923

  Maccalli, Cristina ^a   Pisarra, Patrizia ^a   Vegetti, Claudia ^a   Sensi, Marialuisa ^a   Parmiani, Giorgio ^a   Anichini, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; COCULTURE; FEMALE; HLA SYSTEM; HUMAN; IMMUNOFLUORESCENCE TEST; MALE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; CELL-FREE SYSTEM; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MALE; MELANOMA; MEMBRANE PROTEINS; MIDDLE AGED; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIGNAL TRANSDUCTION; SOLUBILITY; SUPPRESSOR FACTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; TUMOR CELLS, CULTURED; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 0032715757     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Miescher, S., T. L. Whiteside, S. Carrel, and V. Von Fliedner. 1986. Functional properties of tumor infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol. 136:1899.
2. Miescher, S., M. Stoeck, L. Qiao, C. Barras, L. Barrelet, and V. Von Fliedner. 1988. Proliferative and cytolitic potentials of purified human tumor-infiltrating T lymphocytes: impaired response to mitogen-driven stimulation despite T-cell receptor expression. Int. J. Cancer 42:659.
3. Yoshino, I., T. Yuno, M. Murata, T. Ishida, K. Sugimachi, G. Kimura, and K. Nomoto. 1992. Tumor-reactive T-cells accumulate in lung cancer tissues hut fail to respond due to tumor cell-derived factor. Cancer Res. 52:775.
4. Alexander, J. P., S. Kudoh, K. A. Melsop, T. A. Hamilton, M. G. Edinger, R. R. Tubbs, D. Sica, L. Tuason, E. Klein, R. M. Bukowski, and J.H. Finke. 1993. T-cell infiltrating renal cell carcinoma display a poor proliferative response even though they can produce IL-2 and express IL-2 receptors. Cancer Res. 53:1380.
5. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res. 53:5613.
6. Tartour, E., S. Latour, C. Mathiot, N. Thiounn, V. Mosseri, I. Joyeux, C. Dubois D'Enghien, L. Renshiang, B. Debre, and W. H. Fridman. 1995. Variable expression of CD3-ζ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int. J. Cancer 63:205.
7. Matsuda, M., M. Petersson, R. Lenkei, J. L. Taupin, I. Magnusson, H. Mellstedt, P. Anderson, and R. Kiessling. 1995. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int. J. Cancer 61:765.
8. Nakagomi, H., M. Petersson, I. Magnusson, C. Juhlin, M. Matsuda, J. L. Taupin, E. Vivier, P. Anderson, and R. Kiessling. 1993. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res. 53:5610.
9. Cabrera, T., A. Collado, M. A. Fernandez, A. Ferron, J. Sancho, F. Ruiz-Cabello, and F. Garrido. 1998. High frequency of altered HLA class 1 phenotypes in invasive colorectal carcinomas. Tissue Antigens 52:114.
10. Farace, F., E. Angevin, J. Vanderplancke, B. Escudier, and F. Triebel. 1994. The decreased expression of CD3 ζ chains in cancer patients is not reversed by IL-2 administration. Int. J. Cancer 59:752.
11. Kono, K., M. E. Ressing, R. M. P. Brandt, C. J. M. Melief, R. K. Potkul, B. Andersson, M. Petersson, M. Kast, and R. Kiessling. 1996. Decreased expression of signal-transducing ζ chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin. Cancer Res. 2:1825.
12. Rossi, E., E. Matutes, R. Morilla, K. Owusu-Ankomah, A. M. Heffernan, and D. Catovsky. 1996. ζ Chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. Leukemia 10:494.
13. Zea, A. H., B. D. Cutri, D. L. Longo, W. G. Alvord, S. L., Strobl, H. Mizoguchi, S. P. Creekmore, J. J. O'Shea, G. C. Powers, W. J. Urba, and A. C. Ochoa. 1995. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin. Cancer Res. 1:1327.
14. Salvadori, C. B., A. Gansbacher, A. Pizzimenti, and K. I. Zier. 1994. Abnormal signal transduction by T cells of mice with parental tumor is not seen in mice bearing IL-2 secreting tumors. J. Immunol. 153:5176.
15. Noda, S., T. Nagata-Narumiya, A. Kosugi, S. Narumiya, C. Ra, H. Fujiwara, and T. Hamaoka. 1995. Do structural changes of T cell receptor complex occur in tumor-bearing state? Jpn. J. Cancer Res. 86:383.
16. Rabinowich, H., M. Banks, T. E. Reichert, T. F. Logan, J. M. Kirkwood, and T. L. Whiteside. 1996. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Clin. Cancer Res. 2:1263.
17. Correa, M. R., A. C. Ochoa, P. Ghosh, H. Mizoguchi, L. Harvey, and D. L. Longo. 1997. Sequential development of structural and functional alterations in T cells from tumor-bearing mice. J. Immunol. 158:5292.
18. Kurt, R. A., W. J. Urba, J. W. Smith, and D. D. Schoof. 1998. Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules. Int. J. Cancer 78:16.
19. Wang, Q., J. Stanley, S. Kudoh, J. Myles, V. Kolenko, T. Yi, R. Tubbs, R. Bukowski, and J. Finke. 1995. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. J. Immunol. 155:1382.
20. Fargnoli, M. C., R. L. Edelson, C. L. Berger, S. Chimenti, C. Couture, T. Mustelin, and R. Halaban. 1997. Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of ZAP70, Syk and membrane-associated Csk. Leukemia 11:1338.
21. Mulder, W. M. C., E. Bloemena, M. J. Stukart, J. A. Kummer, J. Wagstaff, and R. J. Scheper. 1997. T cell receptor-ζ and granzyme B expression in mononuclear cell infiltrates in colon carcinoma. Gut 40:153.
22. Guarini, A., L. Riera, A. Cignetti, L. Montacchini, M. Massaia, and R. Foa. 1997. Transfer of interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules. Blood 89:212.
23. Kolenko, V., Q. Wang, M. C. Riedy, J. O'Shea, J. Ritz, M. K. Cathcart, P. Rayman, R. Tubbs, M. Edinger, A. Novick, et al. 1997. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling. J. Immunol. 159:3057.
24. Aoe, T., Y. Okamoto, and T. Saito. 1995. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J. Exp. Med. 181:1881.
25. Otsuji, M., Y. Kimura, T. Aoe, Y. Okamoto, and T. Saito. 1996. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 ζ chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl. Acad. Sci. USA 93:13119.
26. Maccalli, C., C. Farina, M. L. Sensi, G. Parmiani, and A. Anichini. 1997. TCR β chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201 melanoma patients. J. Immunol. 158:5902.
27. Sander, B., J. Andersson, and U. Andersson. 1991. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 119:65.
28. Makgoba, M. W., M. W. Sanders, G. E. Luce, M. Dustin, T. A. Springer, E. A. Clark, P. Mannoni, and S. Shaw. 1988. ICAM-1, a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature 331:86.
29. Espevick, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99.
30. Hansen, M. B., S. E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119:203.
31. fvn, ZAP-70, and CD3 ζ despite suppressed cytolytic activity J. Exp. Med. 182:1029.
32. Zavazava, N., and M. Kronke. 1996. Soluble HLA class 1 molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat. Med. 9:1005.
33. Zavazava, N. 1998. Soluble HLA class 1 molecules: biological significance and clinical implications Mol. Med. Today 4:116.
34. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signaling: altered phospho-ζ and lack of ZAP70 recruitment in APL-induced T cell anergy. Cell 79: 913.
35. Lee, J. E., M. B. Cossoy, L. A. Chau, B. Singh, and J. Madrenas. 1997. Inactivation of lck and loss of TCR-mediated signaling upon persistent engagement with complexes of peptide: MHC molecules. J. Immunol. 159:61.
36. 35. Cancer Res. 58:2433.
37. Tang, B., L. K. Myers, E. F. Rosloniec, K. B. Whittington, J. M. Stuart, and A. H. Kang. 1998. Characterization of signal transduction through the TCR-ζ chain following T cell stimulation with analogue peptides of type II collagen 260-267. J. Immunol. 160:3135.
38. Sensi, M. L., and G. Parmiani. 1995. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol. Today 16: 588.
39. Renner, C., S. Ohnesorege, G. Held, S. Bauer, W. Jung, J. P. Pfitzenmeier, and M. Pfreundschuh. 1996. T cells from patients with Hodgkin's disease have a defective T-cell receptor ζ chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood 88:236.